29Jul
National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer
On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s...
By:
Manatt, Phelps & Phillips, LLP
Related
The Ministry of Manpower has issued Ministerial Decision 47/2020 (the MD). The MD adds "sales repres...
Read More >
Delaware Bankruptcy Judge Brendan Shannon granted mechanic’s lien claimants $1.6 million for making...
Read More >
The UK Court of Appeal (the CoA) issued its judgment on 13 June in the case of Kostal UK Ltd v Dale ...
Read More >
As the final segment in our series of alerts detailing key provisions of SB75, the anti-harassment l...
Read More >
On December 13, 2019, the National Labor Relations Board (“NLRB” or the “Board”) issued a propos...
Read More >
SMALL BUSINESS PROGRAMS & ADVISORY SERVICES - CLIENT ALERT: SBA to Increase Size Standards with In...
Read More >